Evidence map›Paper›PMID 41452483›Full record

ArticlePituitary2025

Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates.

Banu Betul Kocaman, Yusuf Cicek, Serdar Sahin, Ahmet Burhan Dogan, Serhat Uysal, Ilkin Muradov, Lala Soltanova, Sabriye Sibel Taze, Nazife Gamze Usta Saglam, Emre Durcan and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pituitary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Banu Betul KocamanDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0009-0004-9281-1771
Yusuf CicekDepartment of Psychiatry, Cerrahpasa Faculty of Medicine, Istanbul University- Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0003-1225-9426
Serdar SahinDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-6233-5418
Ahmet Burhan DoganDepartment of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University- Cerrahpasa, Istanbul, Türkiye.
Serhat UysalDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-0507-6966
Ilkin MuradovDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-1906-0535
Lala SoltanovaDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-4420-4721
Sabriye Sibel TazeDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
Nazife Gamze Usta SaglamDepartment of Psychiatry, Cerrahpasa Faculty of Medicine, Istanbul University- Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0003-4727-2460
Emre DurcanDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0001-6803-4977
Senol TuranDepartment of Psychiatry, Cerrahpasa Faculty of Medicine, Istanbul University- Cerrahpasa, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-8684-2617
Pinar KadiogluDivision of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye. pinar.kadioglu@iuc.edu.tr.ORCID http://orcid.org/0000-0002-8329-140X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study evaluated temperament, character dimensions, anxiety, depression, and quality of life (qol) in patients with acromegaly, and examined their associations with clinical variables including disease activity, duration, treatment modality, and tumor characteristics.

methodsIn a cross-sectional study, 77 patients with acromegaly and 99 healthy controls with no difference in age and sex compared to patients completed the Temperament and Character Inventory-Revised (TCI-R), Hospital Anxiety and Depression Scale (HADS), and Acromegaly Quality of Life Questionnaire (AcroQoL). Patients were subgrouped by remission status, treatment type, and histopathological findings. Between-group comparisons and correlation analyses were performed.

resultsCompared with controls, patients with acromegaly exhibited higher impulsiveness but lower levels of emotional warmth, persistence, and self-directedness. Higher self-acceptance scores were associated with remission, while female patients exhibited significantly lower AcroQoL-Physical scores than male patients. IGF-1 levels positively correlated with novelty seeking. Qol was negatively correlated with harm avoidance, anxiety, and depression, whereas both anxiety and depression were positively associated with harm avoidance.

conclusionsAcromegaly is associated with distinct personality patterns that may influence coping, well-being, and treatment experiences. These findings underscore the potential value of integrating psychosocial assessment and personalized support into the management of acromegaly, and highlight the need for further studies to clarify underlying neurobiological and cultural influences.

Indexed as

AcromegalyPersonalityTemperamentAdenomaAdolescentAdultAnxietyCross-Sectional StudiesDepressionFemaleHumansInsulin-Like Growth Factor IMaleMood DisordersQuality of LifeSelf-ManagementInsulin-Like Growth Factor IAcromegalyAnxiety and depressionPersonality traitsQuality of lifeTemperament and characterTreatment modalities

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.